Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial

Background: Coronavirus disease 2019 (COVID-19) was declared a global pandemic in March 2020 by the World Health Organization (WHO). As of July 2, 2022, COVID-19 has caused more than 545 million infections and 6.3 million deaths worldwide, posing a significant threat to human health. Currently, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yangyang, Chen, Xi, Wang, Hongan, Yao, Chensi, Gou, Xiaowen, Gao, Zezheng, Sun, Linlin, Liu, Dan, Tang, Cheng, Wei, Yu, Ding, Qiyou, Yang, Haoyu, Lin, Jiaran, Chen, Keyu, Chen, Jia, Zhao, Linhua, Li, Min, Han, Lin, Wang, Jian, Ren, Jixiang, Zhang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425051/
https://www.ncbi.nlm.nih.gov/pubmed/36052134
http://dx.doi.org/10.3389/fphar.2022.936925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425051/
https://www.ncbi.nlm.nih.gov/pubmed/36052134
http://dx.doi.org/10.3389/fphar.2022.936925

Ejemplares similares